After debuting on the public markets with $256.3 million and raking in an additional $472 million, Veradermics has emerged as one of biotech’s biggest post-IPO standouts. CEO Reid Waldman credits the weight loss craze for establishing consumer-driven channels.
Hair loss biotech Veradermics, up 656% since its IPO, credits the obesity boom Read More »
The rule, released Thursday, builds on Trump administration’s priorities, including cutting Medicare reimbursement for drugs in the controversial 340B program and equalizing payment between sites of care.
The centerpiece of the acquisition is Myricx Bio’s novel N-myristoyltransferase inhibitor payload platform, which could help Novartis develop antibody-drug conjugates that can overcome the limitations of existing therapies.
Novartis drops up to $1.5B for ADC specialist Myricx, continuing cancer spending spree Read More »
Scribe Therapeutics’ pipeline is immature, with its lead program recently greenlit for first-in-human testing. The biotech is working on CRISPR-based therapies for cardiometabolic diseases.
Early-stage Scribe wants to write IPO story even as investors favor derisked portfolios Read More »
BridgeBio’s Attruby preserves kidney function in patients with transthyretin amyloidosis cardiomyopathy, an effect that is “distinct” from other drugs in this space, according to Jefferies.
Cuando pensamos en los grandes hitos de la medicina y la biología del siglo XX —como la secuenciación del genoma humano o el desarrollo de fármacos dirigidos contra el cáncer—, solemos imaginar a científicos con batas blancas rodeados de tubos de ensayo …
Noticias de la actualidad astronómica y astronáutica del 6 de julio de 2026. …
See the grades RAAPID’s customers gave in the 2026 KLAS Emerging Company Spotlight.
Healthcare systems are turning to modular construction to reduce risk and accelerate delivery.
Why healthcare construction timelines are now operational risks Read More »
El curso de la humanidad ha sido moldeado por giros inesperados, pero pocos tan radicales como el que ocurrió en los “laboratorios” de la China imperial del siglo IX. Lo que comenzó como la búsqueda mística de un elixir para alcanzar la inmortalidad termin&oac …
